Unum posts higher Q2 revenue
Overview
Unum Q2 2025 revenue largely in line with analyst expectations, per LSEG data, driven by premium growth in co's capital-efficient, high-return businesses
Net income for Q2 2025 declines to $335.6 mln from $389.5 mln yr/yr
Co revises full-year 2025 after-tax adjusted operating income per share outlook
Outlook
Company revises full-year 2025 after-tax adjusted operating income per share outlook to $8.50
Revises full year share repurchase expectation to the top end of co's outlook range of $500 million to $1.0 billion
Company confident in executing growth strategy with strong capital position
Result Drivers
PREMIUM GROWTH - Unum reports 4.6% premium growth on a constant currency basis, driven by core operations
REINSURANCE TRANSACTION - Successfully closed long-term care reinsurance transaction, reducing exposure to closed block
CAPITAL MANAGEMENT - Repurchased $300 mln of shares in Q2, revising full-year repurchase expectation to $500 mln to $1 bln
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Meet | $3.36 bln | $3.34 bln (7 Analysts) |
Q2 EPS | $1.92 | ||
Q2 Net Income | $335.60 mln | ||
Q2 Adjusted Operating Income | $361.10 mln | ||
Q2 Pretax Profit | $417 mln |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the life & health insurance peer group is "buy"
Wall Street's median 12-month price target for Unum Group is $95.50, about 16.1% above its July 28 closing price of $80.08
The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 9 three months ago
Press Release: